Ars Technica's John Timmer notes Kappos is a nominee who, despite being an outspoken advocate of patent reform, is being accepted even by industries such as biotech that are not keen on changing the system: Even if some groups disagree with the specific reforms Kappos has proposed, they are anxious to see someone with demonstrated competence and experience in charge of the USPTO, someone who at leas